(Adnkronos Health) – “Clinical research in Italy today has to contend with some structural issues – emphasizes Alessandro Rambaldi, scientific director of From, Foundation for Research at Bergamo Hospital Ets –. The first is the scarcity of funding, the second is excessive bureaucratization of the procedures to obtain it, even at a European level: the need for expenditure control is understandable, but the consequence of this excess bureaucracy is the marked lengthening of research times and the growth of its indirect costs, linked to administrative aspects. The third point concerns animal experimentation, which in Italy has become particularly difficult and extremely burdensome. Finally, it is fundamental that large hospitals, such as Papa Giovanni XXIII in Bergamo, have the possibility to extract useful information and data from daily clinical experience to study the outcomes of treatments. And this, unfortunately, is a wealth of knowledge increasingly difficult to use due to certain privacy regulations: the protection of patients’ personal data, adequately processed and anonymized, remains an indispensable principle, but it must not become an obstacle to scientific research that aims to improve the care and quality of life of the patients involved and beyond.”
“Never before in this historical moment has the need to recognize clinical research as an integral part of the care pathway emerged so clearly – adds Stefano Stabile, Gcp Quality Assurance Manager, Asst Grande Ospedale Metropolitano Niguarda –. In this context, it becomes fundamental to value and recognize, professionally and contractually, the figures who carry out clinical research every day within hospitals and research centers: from Study Coordinators to research nurses. Gidm has been fighting for years to achieve this goal, aware that it is essential to promote constant and constructive dialogue among all involved stakeholders and institutions. For this reason too, events like today’s represent precious and important opportunities: moments of discussion, sharing, and dialogue, indispensable for continuing to build the future of clinical research together.”
“We are convinced that the development of a Clinical Trial Center model – concludes Giulia Peruzzotti, director of the Ieo Clinical Trial Center – capable of making clinical research more efficient, competitive, safe, and sustainable, is a strategic lever to transform scientific excellence into concrete opportunities for patients, through multidisciplinary skills, technological innovation, and integrated care pathways.”